JanssenScientists3-hires.jpg
JanssenScientists3-hires.jpg
Our Approach

Engaging with Our Stakeholders

GRI
Global Reporting Initiative
102-12
External initiatives
102-13
Membership associations
102-21
Consulting stakeholders on economic, environmental, and social topics
102-40
List of stakeholder groups
102-42
Identifying and selecting stakeholders
102-43
Approach to stakeholder engagement
102-44
Key topics and concerns raised

As a global healthcare company, we interact with numerous stakeholder groups at the global, national and local levels. Our Credo, written 75 years ago, acknowledges the diversity of stakeholders to whom we are responsible, and serves as our guide. Such engagement helps us learn about emerging sustainability topics while supporting Johnson & Johnson in creating long-term value for our Company and society.

The deep and longstanding relationships we cultivate with our stakeholders are vital to both our Credo-driven business strategies and our citizenship and sustainability approach. Our broad and consistent stakeholder engagement is essential to building successful business strategies and achieving our goal to deliver the best products and services possible.

Stakeholder engagement occurs at all levels of the Company, and information gained through these interactions is communicated through line management and, as appropriate, to senior management, including the Johnson & Johnson Executive Committee and Board of Directors. The goal of our decentralized approach is to connect our stakeholders with the most appropriate internal resources to address their needs and concerns, which benefits both our business and our stakeholders. As necessary to ensure consistency of approach, for broad-based stakeholder engagements we leverage a customer relationship management system to provide visibility and management across the Enterprise.

In determining with whom to engage with respect to environment, social and governance topics, we take into consideration a variety of factors, including:

  • Alignment of our goals and values with those of the stakeholder group;
  • Ability to improve human health, social, environmental and other outcomes because of this engagement;
  • Opportunity for mutual learning.

Throughout 2018, members of our management team met with a significant number of our shareholders to discuss our Health for Humanity sustainability approach. This includes our Health for Humanity 2020 Goals and other citizenship and sustainability commitments, as well as transparency around key environmental, social and governance measures. We hosted our first Health for Humanity Report webinar with investors to accompany the release of our annual Health for Humanity Report, providing shareholders the opportunity to engage and ask questions of leaders in Investor Relations, Product Quality & Compliance, Medical Safety, Global Public Health and Environmental Health, Safety and Sustainability.

To ensure we’re always investing for the future, we’re participating in important initiatives like the Embankment Project for Inclusive Capitalism, CECP’s Strategic Investor Initiative and the Business Roundtable. With these expert partners, we’re helping to shift the conversation in the financial markets toward a long-term view and measurement of the value to society that a business like ours creates.

We also partnered with Business for Social Responsibility (BSR), a global nonprofit organization focused on corporate sustainability, on a formalized stakeholder feedback initiative. BSR solicited reactions and insights on the 2017 Health for Humanity Report content from a broad base of stakeholders reflecting global public health institutions, investors, NGOs, and environmental leaders. Their guidance and feedback have been integrated into the 2018 Health for Humanity Report. In addition, this stakeholder feedback has been integrated into business and functional group strategies across the Enterprise, and the important insights will inform our 2019 Priority Topics Assessment and Health for Humanity 2025 goal setting.

Stakeholder Engagement on This Report

Various internal stakeholders across Johnson & Johnson's global teams provided their input into this Report. The final content has been reviewed by the members of the Executive Committee.

Our Stakeholders

Advocacy Groups / Trade Associations

Methods of Engagement:
Organizational memberships, direct engagement, dialogue, sponsorships, conferences, research efforts

Issues:
Product quality, safety and reliability, ethical business practices and performance, access to and affordability of medicines, global public health, community engagement and impact, product innovation, diversity, responsible sourcing, ingredient issues, workplace safety 

Consumers

Methods of Engagement:
Dedicated 24-hour, 7-days-a-week toll-free hotline in 23 languages, Johnson & Johnson website, brand websites, social media, focus groups, clinical trials

Issues:
Product quality, safety and reliability, proper product use, access to our products, materials/ingredients in our products, data protection and privacy, socially beneficial products, proper disposal of products, ethical behavior and performance 

Customers

Methods of Engagement:
Direct contact through sales, customer relationship managers, customer call centers, customer meetings, industry trade groups/meetings

Issues:
Product quality, safety and reliability, sales and distributions, supply and demand for products, ethical business practices, data protection and privacy, issues related to products, packaging, product end of life, pricing, manufacturing processes 

Employees

Methods of Engagement:
Our Credo survey, intranets, newsletters, company webcasts, town hall meetings, quarterly business updates, training sessions, anonymous 24-hour, 7-days-a-week tollfree hotline in 23 languages

Issues:
Ethical business practices, business performance, sustainable innovation, workplace health and safety, human capital development, diversity and inclusion, human rights, access to and affordability of medicines, data protection and privacy 

Government / Policy Makers

Methods of Engagement:
Governmental affairs liaisons, direct engagement, Johnson & Johnson Political Action Committee, meetings, advocacy

Issues
Compliance with regulations, ethical business practices, research and development activities, innovation in healthcare, pricing, access, policy positions, marketing practices 

Healthcare Providers

Methods of Engagement:
Sales representatives, continuing medical education liaisons, education initiatives, clinical researchers, advisory boards, support and education programs for caregivers

Issues:
Product quality, safety and reliability, workplace health and safety, human rights, ethical business practices, product pricing and availability, access to and affordability of medicines, employee health and wellness, human capital development 

Socially Responsible Investors

Methods of Engagement:
Annual report, annual sustainability report, annual shareholders meeting, investor releases, quarterly earnings, road shows, completion of surveys, Johnson & Johnson website, conferences, dialogue, direct engagement

Issues:
Product quality, safety and reliability, workplace health and safety, human rights, ethical business practices, product pricing and availability, access to and affordability of medicines, employee health and wellness, human capital development 

Local Communities

Methods of Engagement:
Direct local engagement, philanthropic efforts, employee volunteers, sponsorships, collaborative partnerships

Issues:
Environmental issues, site expansions or closures, employment, transportation, safety and health issues, emergency planning, local community issues, volunteer efforts 

NGOs

Methods of Engagement:
Direct engagement, dialogue, collaborative partnerships, sponsorships, organizational memberships, conferences, social media

Issues:
Diverse organizations with interests across all areas of our business 

Quasi-Governmental Organizations / Academic Institutions

Methods of Engagement:
Direct engagement, collaborative partnerships, face-to-face meetings, research, academic studies

Issues:
Product quality, safety and reliability, studying/addressing health issues, ethical business practices 

Suppliers

Methods of Engagement:
Direct engagement, collaborative partnerships, Responsibility Standards for Suppliers, outreach by category leaders, supplier scorecards, face-to-face meetings, trainings and workshops, supplier diversity initiatives, surveys, assessments and audits

Issues:
Product quality, safety and reliability, ethical business practices, procurement practices, workplace health and safety, environmental and sustainability practices, human rights in the workplace, data protection and privacy, product innovation, diversity and inclusion 

Memberships

We participate in many non-governmental and advocacy organizations and industry associations on topics of interest and priority to the Company. Select memberships and associations include:

  • Advanced Medical Technology Association
  • Asia Pacific Medical Technology Association
  • Association for the Advancement of Medical Instrumentation
  • Bill & Melinda Gates Foundation
  • Biotechnology Industry Organization
  • BIO Ventures for Global Health
  • Business Roundtable
  • California Healthcare Institute
  • CDP (formerly titled Carbon Disclosure Project)
  • Chief Executives for Corporate Purpose (CECP) Strategic Investor Initiative
  • Children Without Worms
  • Climate Leadership Council
  • Closed Loop Fund
  • Consumer Goods Forum
  • Consumer Healthcare Products Association
  • Corporate Eco Forum
  • Cosmetics Europe
  • Council of Supply Chain Manufacturing Professionals
  • Embankment Project for Inclusive Capitalism
  • European Federation of Pharmaceutical Industries and Associations
  • GS1
  • Harvard Medical School
  • Healthcare Businesswomen’s Association
  • HealthCare Institute of New Jersey
  • Healthcare Leadership Council
  • Medtech Europe
  • National Health Council
  • New Horizons Collaborative
  • New York University School of Medicine
  • Personal Care Products Council
  • Pharmaceutical Research and Manufacturers of America
  • Pharmaceutical Supply Chain Initiative
  • The Conference Board
  • The Sustainability Consortium
  • United Nations
  • United Nations Global Compact
  • United States Agency for International Development
  • U.S. Chamber of Commerce
  • United Way – local chapters
  • World Health Organization
Back To Setting Priorities
Up Next Better Health for All
You are leaving jnj.com and entering a third party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties. Continue